PALO ALTO, Calif., Nov. 11, 2010 /PRNewswire-FirstCall/ — Jazz
Pharmaceuticals, Inc. (Nasdaq:
JAZZ) announced today that Bruce Cozadd, the company’s chairman
and chief executive officer, will present at the Lazard Capital
Markets Healthcare Conference in New York on Wednesday, November
17, 2010 at 9:00 a.m. Eastern Time.
A live webcast of the presentation may be accessed from the
Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com.
Please connect to the website prior to the start of the conference
call to ensure adequate time for any software downloads that may be
necessary to listen to the webcast.
An archived version of the webcast will be available for at
least one week on the Investors section of the company’s website at
www.jazzpharmaceuticals.com.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals (Nasdaq:
JAZZ) is a specialty pharmaceutical company that identifies,
develops and commercializes innovative treatments for important,
underserved markets in neurology and psychiatry. For further
information see www.jazzpharmaceuticals.com.
‘/>”/>
